General Information
Version
1.0
Revision date
2021-09-09
Product name
Prusament Resin Tough Anthracite Grey
Emergency telephone
Comment
Icons in SDS
Company Information
company name
Prusa Research a.s
e-mail address of the competent person responsible for the Safety Data Sheet
info@prusa3d.cz
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H411
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
May cause an allergic skin reaction. Causes skin irritation. Causes serious eye irritation. Toxic to aquatic life with long lasting effects.
2.2 Label elements
Labelling
Hazard pictograms
GHS07 GHS09
Signal word
Warning
Contains
Propoxylated neopentylglycol diacrylate, Tricyclodecane dimethanol diacrylate
Hazard statements
H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H411 - Toxic to aquatic life with long lasting effects.
Precautionary statements
P261 - Avoid breathing vapours. P264 - Wash hands, forearms and face thoroughly after handling. P273 - Avoid release to the environment. P280 - Wear protective gloves, protective clothing, eye protection/face protection. P302+P352 - IF ON SKIN: Wash with plenty of soap and water. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337+P313 - If eye irritation persists: Get medical advice/attention. P362+P364 - Take off contaminated clothing and wash it before reuse. P501 - Dispose of contents/container to an approved waste disposal plant.
2.3 Other hazards
This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605